Business Daily.
.
A+ R A-

The Conversation

The US Food and Drug Administration has just approved the use of lisdexamfetamine dimesylate for the treatment of binge eating disorder. Licensed under the brand name Vyvanse, lisdexamfetamine is the first and only FDA-approved medication for this condition.

But Vyvanse has already been on the market since 2007 as a daily treatment for attention...

Page 24771 of 27002

The Conversation


Grow Your Business with Times Media

Business Daily Media